Aquilo Capital, L.P., 10% Owner at Spero Therapeutics, Inc. (SPRO), sold 279,866 shares at $18.62 ($5.3M) on 2020-12-16, disclosed to the SEC on 2020-12-18.
Open-market sale of $5.3M SPRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.62 | 14,933 | $278K | 5.3% |
| 2 | $18.62 | 14,933 | $278K | 5.3% |
| 3 | $18.81 | 250,000 | $4.7M | 89.4% |
| Total | $18.79 avg | 279,866 | $5.3M | 100% |
| Filing → |
| SPRO | BUY | 2022-03-02 | $855K | — | Filing → |
| SPRO | BUY | 2022-01-26 | $17K | — | Filing → |
| SPRO | BUY | 2021-11-02 | $2.6M | — | Filing → |